Pfizer argues that the cost of drugs is simply not relevant to the issue of access to most medicines in the developing world, citing as evidence the low utilisation rates of very cheap generic drugs for pneumonia, TB and malaria. Oxfam accepts that the causes of the public health crisis in developing countries are complex. But limited access to life-saving drugs that are widely-available in rich countries is also central to any explanation.